Literature DB >> 20868626

Shifted helical computed tomography to optimize cardiac positron emission tomography-computed tomography coregistration: quantitative improvement and limitations.

Nils P Johnson1, Tinsu Pan, K Lance Gould.   

Abstract

Positron emission tomography-computed tomography (PET-CT) uses CT attenuation correction but suffers from misregistration artifacts. However, the quantitative accuracy of helical versus cine CT in the same patient after optimized coregistration by shifting both CT data as needed for each patient is unknown. We studied 293 patients undergoing cardiac perfusion PET-CT using helical CT attenuation correction for comparison to cine CT. Objective, quantitative criteria identified perfusion abnormalities that were associated visually with PET-CT misregistration. Custom software shifted CT data to optimize coregistration with quantitative artifact improvement. The majority (58.1%) of cases with both helical and shifted helical CT data (n  = 93) had artifacts that improved or resolved by software shifting helical CT data. Translation of shifted helical CT was greatest in the x-direction (8.8 ± 3.3 mm) and less in the y- and z-directions (approximately 3.5 mm). The magnitude of differences in quantitative end points was greatest for helical (p  =  .0001, n  =  177 studies), less for shifted helical but significant (p  =  .0001, n  =  93 studies), and least for cine (not significant, n  =  161 studies) CT compared to optimal attenuation correction for each patient. Frequent artifacts owing to attenuation-emission misregistration are substantially corrected by software shifting helical CT scans to achieve proper coregistration that, however, remains on average significantly inferior to cine CT attenuation quantitatively.

Entities:  

Mesh:

Year:  2010        PMID: 20868626      PMCID: PMC9128568     

Source DB:  PubMed          Journal:  Mol Imaging        ISSN: 1535-3508            Impact factor:   3.250


  22 in total

1.  Respiration-induced attenuation artifact at PET/CT: technical considerations.

Authors:  Gerhard W Goerres; Cyrill Burger; Ehab Kamel; Burkhardt Seifert; Achim H Kaim; Alfred Buck; Tobias C Buehler; Gustav K Von Schulthess
Journal:  Radiology       Date:  2003-03       Impact factor: 11.105

2.  Common artifacts in PET myocardial perfusion images due to attenuation-emission misregistration: clinical significance, causes, and solutions.

Authors:  Catalin Loghin; Stefano Sdringola; K Lance Gould
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

3.  Mechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-up.

Authors:  Stefano Sdringola; Catalin Loghin; Fernando Boccalandro; K Lance Gould
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

4.  Artifacts from misaligned CT in cardiac perfusion PET/CT studies: frequency, effects, and potential solutions.

Authors:  Axel Martinez-Möller; Michael Souvatzoglou; Nassir Navab; Markus Schwaiger; Stephan G Nekolla
Journal:  J Nucl Med       Date:  2007-02       Impact factor: 10.057

5.  Attenuation correction in cardiac PET/CT with three different CT protocols: a comparison with conventional PET.

Authors:  Michael Souvatzoglou; Frank Bengel; Raymonde Busch; Coletta Kruschke; Helga Fernolendt; Denise Lee; Markus Schwaiger; Stephan G Nekolla
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07-28       Impact factor: 9.236

6.  Attenuation correction of PET cardiac data with low-dose average CT in PET/CT.

Authors:  Tinsu Pan; Osama Mawlawi; Dershan Luo; Hui H Liu; Pai-Chun M Chi; Martha V Mar; Gregory Gladish; Mylene Truong; Jeremy Erasmus; Zhongxing Liao; H A Macapinlac
Journal:  Med Phys       Date:  2006-10       Impact factor: 4.071

7.  Cine CT for attenuation correction in cardiac PET/CT.

Authors:  Adam M Alessio; Steve Kohlmyer; Kelley Branch; Grace Chen; James Caldwell; Paul Kinahan
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

8.  Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease.

Authors:  Stefano Sdringola; Keiichi Nakagawa; Yuko Nakagawa; S Wamique Yusuf; Fernando Boccalandro; Nizar Mullani; Mary Haynie; Mary Jane Hess; K Lance Gould
Journal:  J Am Coll Cardiol       Date:  2003-01-15       Impact factor: 24.094

9.  Minimizing artifacts resulting from respiratory and cardiac motion by optimization of the transmission scan in cardiac PET/CT.

Authors:  Jonathon A Nye; Fabio Esteves; John R Votaw
Journal:  Med Phys       Date:  2007-06       Impact factor: 4.071

10.  Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium.

Authors:  K L Gould; J P Martucci; D I Goldberg; M J Hess; R P Edens; R Latifi; S J Dudrick
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

View more
  2 in total

Review 1.  Quantitative Coronary Physiology for Clinical Management: the Imaging Standard.

Authors:  K Lance Gould; Nils P Johnson
Journal:  Curr Cardiol Rep       Date:  2016-01       Impact factor: 2.931

2.  Optimizing quantitative myocardial perfusion by positron emission tomography for guiding CAD management.

Authors:  K Lance Gould
Journal:  J Nucl Cardiol       Date:  2016-09-14       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.